Clinical TrialsOpti-DOR Trial: Doravirine Matches Dolutegravir While Reducing Weight Gain Opti-DOR Trial: Doravirine Matches Dolutegravir While Reducing Weight Gain Read Post »
New Drug ApprovalReckitt’s Mucinex 12HR Cold & Fever Multi-Symptom Becomes First F... Reckitt’s Mucinex 12HR Cold & Fever Multi-Symptom Becomes First F... Read Post »
Health TidingsExpedition Raises $115M to Advance EXPD-101 Phase 2 COPD Trial Expedition Raises $115M to Advance EXPD-101 Phase 2 COPD Trial Read Post »
GenericsZydus announces Final Approval from the USFDA for Indocyanine Green for Inj... Zydus announces Final Approval from the USFDA for Indocyanine Green for Inj... Read Post »
Clinical TrialsRisvodetinib Shows Disease-Modifying Biomarker Effects in Phase 2 Parkinson... Risvodetinib Shows Disease-Modifying Biomarker Effects in Phase 2 Parkinson... Read Post »
Health TidingsFDA Grants RMAT Designation to Lexeo’s LX2020 Gene Therapy for PKP2-A... FDA Grants RMAT Designation to Lexeo’s LX2020 Gene Therapy for PKP2-A... Read Post »
Health TidingsFDA Aligns with Tonix on Phase 2 Study Design for TNX-4800 to Prevent Lyme ... FDA Aligns with Tonix on Phase 2 Study Design for TNX-4800 to Prevent Lyme ... Read Post »
Health TidingsNurix Launches Phase 3 Trial of BTK Degrader Bexobrutideg Nurix Launches Phase 3 Trial of BTK Degrader Bexobrutideg Read Post »
Manufacturing Mergers & AcquisitionsFujifilm, Taiho Partner to Advance Manufacturing of Next-Gen ADCs Fujifilm, Taiho Partner to Advance Manufacturing of Next-Gen ADCs Read Post »
Clinical TrialsModerna Starts Phase 1 Trial of mRNA-1469 Bundibugyo Ebola Vaccine Moderna Starts Phase 1 Trial of mRNA-1469 Bundibugyo Ebola Vaccine Read Post »
Clinical TrialsCadrenal Refocuses CAD-1005 Strategy Following Competitor’s Phase 3 C... Cadrenal Refocuses CAD-1005 Strategy Following Competitor’s Phase 3 C... Read Post »
Clinical TrialsPhase 3 VISIONARY Trial Shows VOYXACT Stabilizes Kidney Function in IgAN Phase 3 VISIONARY Trial Shows VOYXACT Stabilizes Kidney Function in IgAN Read Post »
Health TidingsRoutine Sodium Bicarbonate Fails to Improve Outcomes in Adult In-Hospital C... Routine Sodium Bicarbonate Fails to Improve Outcomes in Adult In-Hospital C... Read Post »
Health TidingsTavapadon Significantly Improved Motor Symptoms in Phase 3 Trial for Early ... Tavapadon Significantly Improved Motor Symptoms in Phase 3 Trial for Early ... Read Post »
Health Tidings Mergers & AcquisitionsEvexta Bio and Roche Partner on Phase 1b Trial of Rupitasertib Plus Giredes... Evexta Bio and Roche Partner on Phase 1b Trial of Rupitasertib Plus Giredes... Read Post »
Clinical TrialsJAK1/2 Inhibition with Low-Dose Ruxolitinib Reduced Acute GVHD in Haploiden... JAK1/2 Inhibition with Low-Dose Ruxolitinib Reduced Acute GVHD in Haploiden... Read Post »
Clinical TrialsRhythm RM-718 Shows 11.6% BMI Reduction in Hypothalamic Obesity Trial Rhythm RM-718 Shows 11.6% BMI Reduction in Hypothalamic Obesity Trial Read Post »
FoodDaily Tomato Intake Reduces Liver Fat in Adults With MASLD Daily Tomato Intake Reduces Liver Fat in Adults With MASLD Read Post »
Clinical TrialsOcular Reports Post Hoc Analysis of Phase 3 SOL-1 Trial Demonstrating Up to... Ocular Reports Post Hoc Analysis of Phase 3 SOL-1 Trial Demonstrating Up to... Read Post »
New Drug ApprovalEU Approves Expanded Indication for Sanofi’s MenQuadfi in Infants from Si... EU Approves Expanded Indication for Sanofi’s MenQuadfi in Infants from Si... Read Post »
Clinical Trials Mergers & AcquisitionsAmplia and Lilly Partner to Advance Narmafotinib Plus Olomorasib for KRAS G... Amplia and Lilly Partner to Advance Narmafotinib Plus Olomorasib for KRAS G... Read Post »
Clinical TrialsAravax Secures FDA Fast Track Designation for PVX108 in Peanut Allergy Aravax Secures FDA Fast Track Designation for PVX108 in Peanut Allergy Read Post »
New Drug ApprovalFresenius Kabi Advances Global Biosimilars Portfolio with FDA, EMA Review o... Fresenius Kabi Advances Global Biosimilars Portfolio with FDA, EMA Review o... Read Post »
Health TidingsAcurx Advances Ibezapolstat Toward Phase 3 Following Positive FDA Feedback Acurx Advances Ibezapolstat Toward Phase 3 Following Positive FDA Feedback Read Post »
Health TidingsFDA Supports Oculis’ Privosegtor for Acute Multiple Sclerosis Relapse... FDA Supports Oculis’ Privosegtor for Acute Multiple Sclerosis Relapse... Read Post »
GenericsFDA Approves Garzulys Biosimilar to NovoLog for Adults and Children with Di... FDA Approves Garzulys Biosimilar to NovoLog for Adults and Children with Di... Read Post »
Clinical Trials Disease & DrugsCan-Fite Launches Phase 2 Clinical Program of Piclidenoson for Rare Genetic... Can-Fite Launches Phase 2 Clinical Program of Piclidenoson for Rare Genetic... Read Post »
Clinical TrialsReal-World Study Supports Long-Term Safety of Arimoclomol in Niemann-Pick D... Real-World Study Supports Long-Term Safety of Arimoclomol in Niemann-Pick D... Read Post »
Health TidingsGefurulimab PREVAIL Trial Shows Benefit in Generalized Myasthenia Gravis Gefurulimab PREVAIL Trial Shows Benefit in Generalized Myasthenia Gravis Read Post »
Health TidingsLilly Secures FDA Breakthrough Therapy Designation for Olomorasib in KRAS G... Lilly Secures FDA Breakthrough Therapy Designation for Olomorasib in KRAS G... Read Post »
Clinical TrialsCAPRISA 012C Trial Reveals Viral Resistance as Key Challenge for Broadly Ne... CAPRISA 012C Trial Reveals Viral Resistance as Key Challenge for Broadly Ne... Read Post »
Clinical TrialsRocket Reports Favorable Early Safety in RP-A501 Trial for Danon Disease Rocket Reports Favorable Early Safety in RP-A501 Trial for Danon Disease Read Post »
Health TidingsZai Lab’s DLL3 ADC Zocilurtatug Pelitecan Receives FDA Orphan Drug Design... Zai Lab’s DLL3 ADC Zocilurtatug Pelitecan Receives FDA Orphan Drug Design... Read Post »
ResearchA Wave of RMAT Designations: What FDA’s Latest Decisions Mean for Reg... A Wave of RMAT Designations: What FDA’s Latest Decisions Mean for Reg... Read Post »
New Drug ApprovalFDA Approves Pluvicto® for PSMA-Positive Metastatic Hormone-Sensitive Pros... FDA Approves Pluvicto® for PSMA-Positive Metastatic Hormone-Sensitive Pros... Read Post »
Health TidingsEvommune Advances Novel MRGPRX2 Therapy to Phase 2b for Migraine Evommune Advances Novel MRGPRX2 Therapy to Phase 2b for Migraine Read Post »
New Drug ApprovalUAE Approves ANKTIVA for Bladder Cancer and Advanced Lung Cancer UAE Approves ANKTIVA for Bladder Cancer and Advanced Lung Cancer Read Post »
